Can a supplement boost mobility and brain power in frail seniors?
NCT ID NCT06027554
First seen Jun 24, 2026 · Last updated Aug 13, 2026 · Updated 3 times
Summary
This study tests whether a daily MitoQ supplement for 12 weeks can improve blood vessel function, walking speed, and thinking skills in frail older adults aged 65-80. Researchers will measure changes in blood flow, cognitive tests, and physical performance. The trial involves 60 participants and compares MitoQ to a placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MitoQ (mitoquinone mesylate) supplement
- What this could lead to
- If it works, this could point toward a simple supplement to help frail older adults move better and think more clearly.
- What could go wrong
- This is a small early-phase trial with only 60 people. The supplement may not work better than a placebo, and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UConn Health
RECRUITINGFarmington, Connecticut, 06030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart sensors at home could spot frailty early and lend a helping hand
- Could your heart hold the key to Alzheimer's prevention?
- Could your brain help unlock Alzheimer's secrets?
- Can a simple test predict Alzheimer's before symptoms worsen?
- The aging Body's hidden water shift: a new study investigates
- Can surgery for stomach or esophageal cancer cloud the mind?